Thulium laser enucleation of the prostate vs bipolar transurethral resection of the prostate in moderate‑to‑large prostates: perioperative and functional outcomes
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Perioperative and functional outcomes of ThuLEP vs bipolar TURP 71 moderate -to -large prostate volume, or in the cases were conservative management failed. 1-3Transurethral resection of prostate (TURP) has always been viewed as the benchmark surgical intervention for BPH.Bipolar TURP has enhanced the safety spectrum of customary monopolar resection, as it uses saline irrigation to diminish the risk of TUR syndrome and achieve better intraoperative hemostasis.2,3 Bipolar TURP is widely used, well known among most urologists, and still provides a satisfactory degree of symptomatic improvement.Nevertheless, in patients with larger prostates, bipolar TURP may be associated with increased INTRODUCTION Benign prostatic hyperplasia (BPH) is a typical age -related urological issue in men and one of the main causes of lower urinary tract symptoms, including urinary frequency, urgency, weak stream, nocturia, and incomplete emptying of the bladder.These symptoms can interfere with the quality of life (QoL) to a large extent and, in extreme cases, lead to complications, such as chronic urinary retention, lower urinary tract infections, and urinary bladder and kidney stones.Although it has been observed that pharmacological therapy is effective in the treatment of patients with mild -to -moderate disease, surgical intervention is at times required in men with
Fields of Study & Subjects
Urinary Bladder and Prostate Research
Prostate Cancer Diagnosis and Treatment
Urologic and reproductive health conditions
Publication details
- Journal / source
- Videosurgery and Other Miniinvasive Techniques
- Volume
- 21
- Issue
- 1
- Pages
- 71–77
- Publication date
- 4 March 2026
- Language
- EN